Infectious Disease Advisor: Antiretroviral therapy linked to increased diabetes risk in HIV

Back to the "HIV and Co-Infections News" list

Infectious Disease Advisor news story

Individuals with HIV experience a substantial burden of diabetes, with antiretroviral therapy (ART) exposure and longer treatment duration associated with a higher incidence of the metabolic condition, according to study results published in HIV Medicine.

As advances in ART have improved survival among individuals with HIV, chronic comorbidities such as diabetes have emerged as increasingly important determinants of long-term health outcomes. Although previous studies have examined the relationship between HIV infection, ART, and diabetes risk, findings have been inconsistent, and the overall incidence of diabetes in this population has remained uncertain.

To better characterize diabetes risk among individuals with HIV, researchers conducted a systematic review and meta-analysis of prospective cohort studies evaluating incident diabetes and prediabetes in adults with HIV. The researchers also assessed differences in diabetes incidence according to HIV status, ART exposure, and ART duration.

Read the full news story here.

/Infectious Disease Advisor requires free registration if more than 5 articles are viewed per month/

 

Get involved

Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?

Subscribe

Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.